Skip to content

Drug interactions

Avatrombopag + Bosentan

Severity: Moderate

Avatrombopag and Bosentan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Bosentan may reduce avatrombopag exposure through CYP3A4 and possibly CYP2C9 induction, potentially diminishing the platelet response.

What this interaction means in plain words

Avatrombopag and Bosentan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Avatrombopag belongs to Miscellaneous; Bosentan belongs to Miscellaneous.

Evidence level: Moderate

Why it happens

Bosentan induces CYP3A4 (and CYP2C9), accelerating avatrombopag clearance.

What to do

Monitor platelet counts and increase avatrombopag dose as recommended in labeling when used with inducers.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Avatrombopag and Bosentan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Avatrombopag with Bosentan?

MediHelp rates the interaction as moderate. Avatrombopag and Bosentan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Bosentan may reduce avatrombopag exposure through CYP3A4 and possibly CYP2C9 induction, potentially diminishing the platelet response.

How serious is the interaction between Avatrombopag and Bosentan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor platelet counts and increase avatrombopag dose as recommended in labeling when used with inducers.

What other medicines interact with Bosentan?

MediHelp also lists interactions of Bosentan with, for example, Cyclosporin, Cyclosporine, Glyburide. The full list is on the Bosentan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in